Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Oct 23 EFFECT Notice of effectiveness
- 10 Oct 23 424B3 Prospectus supplement
- 6 Oct 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
28 Sep 23 S-4 Registration of securities issued in business combination transactions
ZVRA similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
Acer Therapeutics Inc.
Newton, Massachusetts
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 27, 2023, relating to the financial statements of Acer Therapeutics Inc., which is contained in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
BDO USA, P.C.
Boston, Massachusetts
September 28, 2023